Aragen Introduces CHOMax for Rapid IND-Enabling Clinical Supply
Aragen has launched CHOMax, a fully integrated and royalty-free platform designed to accelerate the journey from DNA to IND-enabling clinical supply in approximately 10 months, combining cell line development, process and analytical development and GMP manufacturing with demonstrated high-performance outcomes.
Clinical Supply | 13/01/2026 | By News Bureau
ORIC Pharmaceuticals Signs Clinical Supply Deal with Janssen Research and Development
Under the terms of the agreement, ORIC® will conduct and sponsor the trial and Johnson & Johnson will provide SC amivantamab.
Clinical Supply | 15/01/2025 | By Aishwarya | 319
Novartis to Acquire Mariana Oncology to Expand RLT Pipeline
Novartis has decided to acquire Mariana Oncology, a preclinical-stage biotechnology company based in Watertown, Massachusetts focused on developing novel radioligand therapies (RLTs) to treat cancers with high unmet patient needs.
Clinical Supply | 04/05/2024 | By Aishwarya | 675
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy